Dr. Reddys Laboratories Ltd.

Pursuant to Regulation 23(9) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Reddys Laboratories has informed that it has enclosed the applicable disclosure on related party transactions for the half year ended September 30, 2019, in the requisite format.

The above information is a part of company’s filings submitted to BSE.